Logo

Mainz Biomed and TomaLab Collaborate to Enhance the Diagnosis of Colorectal Cancer Using ColoAlert

Share this
Mainz Biomed

Mainz Biomed and TomaLab Collaborate to Enhance the Diagnosis of Colorectal Cancer Using ColoAlert

Shots:

  • Mainz Biomed has entered into a strategic collaboration with TomaLab to introduce Mainz’ ColoAlert in Italy
  • The collaboration aims at strengthening the screening and diagnosis of colorectal cancer using ColoAlert, enabling patient’s access to the user-friendly diagnostic solution across the Italian healthcare system
  • ColoAlert is a non-invasive and a highly sensitive test that utilizes advanced DNA technology to identify the cancerous and precancerous conditions with greater precision as compared to traditional non-invasive screening procedures for early detection of colorectal cancer

Ref: Mainz Biomed | Image: Mainz Biomed

Related News:- Mainz Biomed Collaborates with Liquid Biosciences to Develop AI Enables Screening Tests for Colorectal Cancer

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Related News/Articles

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions